期刊文献+

基质金属蛋白酶在牙本质龋中的作用

The role of matrix metalloproteinases in dental caries
下载PDF
导出
摘要 基质金属蛋白酶(MMPs)是一类蛋白水解酶,在体内可水解细胞外基质成分。在牙本质龋发生的过程中,致龋菌释放的酸使pH值下降,来自于唾液和牙本质的MMPs被激活,当唾液缓冲系统使pH值恢复中性后,MMPs可水解脱矿的牙本质。基质金属蛋白酶抑制剂如MMPs组织特异性抑制剂及从天然来源的物质中提取出的某些成分可有效抑制MMPs活性。本文就MMPs生物学特性、在牙本质龋中的作用以及其抑制剂的研究进展作一综述。 Matrix metalloproteinases(MMPs) are a family of proteolytic enzyme which are capable of hydrolyzing components of the extracellular matrix(ECM). MMPs originated from saliva and from dentin may be activated by an acidic pH brought about by lactate release from cariogenic bacteria in the progression of dental caries. They are able to digest demineralized dentin matrix after pH neutralization by salivary buffers. Tissue inhibitor of met- alloproteinases(TIMPs) are the physiological inhibitor of the MMPs. Some ...
出处 《国际口腔医学杂志》 CAS 2008年第S1期46-49,共4页 International Journal of Stomatology
关键词 基质金属蛋白酶 牙本质龋 小整合素结合配体N端联结糖蛋白 基质金属蛋白酶抑制剂 matrix metalloproteinases dental caries small integrin-binding ligand N-linked glycoprotein tissue inhibitor of metalloproteinases
  • 相关文献

参考文献1

二级参考文献20

  • 1Kugler A. Matrix metalloproteinases and their inhibitors[ J ]. Anticancer Res, 1999,19(2c) :1589 - 1592.
  • 2Veli-Matti K, Saarialbo-kere U. Matrix metalloproteinases and their inhibitors in tumor growth and invasion [ J ]. Ann Med,1999,31(1) :34 - 45.
  • 3Massova I, Kotra LP, Fridman R, et al. Matrix metalloproteinases: structures, evolution, and diversification[ J ]. FASEB J,1998,12(12): 1075 - 1095.
  • 4Kleiner DE, Stevenson WG. Matrix metalloproteinases and metastasis[ J ]. Cancer Chemother Pharmacol, 1999,43 (Suppl): S42 - S51.
  • 5MacDougall JR, Matrisian LM. Contributions of tumor and stromai matrix metalloproteinases to tumor progession, invasion and metastasis[J]. Cancer Metastasis Rev, 1995,14(4): 351 - 362.
  • 6Wojtowicz-Praga SM,Dickson RB,Hawkins MJ. Matrix metalloproteinase inhibitors[ J ]. Invest New Drugs, 1997,15 (1): 61 - 75.
  • 7Tabot DC, Brown PD. Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer[J]. Eur J Cancer, 1996,32A(14): 2528 - 2533.
  • 8Babine RE, Bender SL. Molecular recognition of protein-ligand complexes: application to drug design [J ]. Chem Rev, 1997,97(5): 1359 - 1472.
  • 9Hidalgo M, Eckhardt SG. Development of matrix metalloproteinase inhibitors in cancer therapy[J]. J Natl Cancer Inst,2001,93(3): 178 - 193.
  • 10Fife RS,Rougraff BT,Proctor C, et al. Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells[ J ]. J Lab Clin Med, 1997,130(5): 530 - 534.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部